Melanotan 2 dosage and half life

Human experiment quantities

The pigmentation pilot began at 0.01 mg/kg and escalated to 0.025–0.03 mg/kg by subcutaneous injection. At 0.03 mg/kg, somnolence limited escalation. The erectile-dysfunction crossover study used 0.025 mg/kg subcutaneously.

These are descriptions of experiments with selected participants. They offer no safe amount for someone reading this page. Melanotan 2 remains unapproved, and the trials were too small to establish routine safety.

I regard the sleepiness at the upper study exposure as an essential finding. Removing the adverse response while circulating the quantity gives a strangely incomplete account of what the investigators observed.

Melanotan 2 half life

A half life describes the time for a measured concentration to fall by half. The research record here contains no validated human pharmacokinetic half life for Melanotan II. Rat clearance data and human measurements of the related Melanotan I have supplied extrapolations, leaving the human MT-II question unresolved.

The historical review distinguishes the molecules and their development. The preformulation paper characterizes Melanotan II through laboratory work and rat data. Neither turns a borrowed clock into a validated human measurement for this peptide.

I need the peptide’s human concentration curve to believe an exact duration. Pigmentation can persist for weeks after peptide clearance because downstream pigment production outlasts the original signal. Visible colour therefore gives a poor clock for the substance in blood.

Hours and “perma dose”

An hours-based estimate and a claim of permanent colour address different things. The small pigmentation study measured a change in skin colour, while the online-forum material describes uneven fading and lingering darker spots. Those personal accounts are anecdotal, not clinical evidence for a predictable duration.

I can give “perma dose” no evidential footing here. The published work establishes no amount that produces a permanent tan. The tanning page describes the actual human result; the effects page follows the changes in moles and other pigmented tissue.

Melanotan 2 injections and other routes

The human trials used injections under the skin. The male-mouse food experiment delivered material directly into the nucleus accumbens, while the female-rat behaviour experiment used a vein. Route and species are substantial differences, so those animal amounts provide no conversion to a human dose.

Unregulated injections add the contents problem documented by product analysis and the blood-borne infection risk associated with needle sharing in the public-health review. Reports of unlicensed nasal use offer no approved alternative. Lab storage and stability findings concern the material tested; they cannot establish the identity or sterility of an unchecked product.